Athira Pharma, Inc. (ATHA)
NASDAQ: ATHA · Real-Time Price · USD
0.2877
-0.0004 (-0.14%)
May 2, 2025, 4:00 PM EDT - Market closed
Athira Pharma Stock Forecast
ATHA's stock price has decreased by -85.9% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Athira Pharma stock have an average target of 11.25, with a low estimate of 0.50 and a high estimate of 22. The average target predicts an increase of 3,810.32% from the current stock price of 0.29.
Analyst Consensus: Buy
* Price targets were last updated on Sep 19, 2024.
Analyst Ratings
The average analyst rating for Athira Pharma stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 3 | 3 | 3 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Mizuho | Mizuho | Buy → Hold Downgrades $5 → $0.5 | Buy → Hold | Downgrades | $5 → $0.5 | +73.79% | Sep 19, 2024 |
JMP Securities | JMP Securities | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Sep 4, 2024 |
BTIG | BTIG | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Sep 4, 2024 |
Rodman & Renshaw | Rodman & Renshaw | Strong Buy Initiates $22 | Strong Buy | Initiates | $22 | +7,546.85% | Aug 19, 2024 |
JMP Securities | JMP Securities | Buy Reiterates $19 | Buy | Reiterates | $19 | +6,504.10% | Jun 20, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.02
from -2.52
EPS Next Year
-0.83
from -1.02
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | n/a | n/a | n/a | ||
Avg | n/a | n/a | n/a | ||
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | -0.88 | -0.85 | -0.81 |
Avg | -1.02 | -0.83 | -0.79 |
Low | -1.13 | -0.79 | -0.75 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.